✦ LIBER ✦

A patient with rheumatoid arthritis treated with tocilizumab together with lamivudine prophylaxis after remission of infliximab-reactivated hepatitis B

✍ Scribed by Hideki Tsuboi; Akira Tsujii; Akihide Nampei; Harumasa Yoshihara; Kiyoshi Kawano; Eiji Takeuchi; Kenrin Shi

Publisher: Springer
Year: 2011
Tongue: English
Weight: 432 KB
Volume: 21
Category: Article
ISSN: 1439-7595
DOI: 10.1007/s10165-011-0470-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A case of lung tuberculosis in a patient

A case of lung tuberculosis in a patient with rheumatoid arthritis treated with infliximab after antituberculosis chemoprophylaxis with isoniazid

✍ Yuji Hirano; Toshihisa Kojima; Yasuhide Kanayama; Hisato Ishikawa; Naoki Ishigur 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 371 KB

Reactivation of hepatitis B in a patient

Reactivation of hepatitis B in a patient with Crohn’s disease treated using infliximab

✍ Keisuke Ojiro; Makoto Naganuma; Hirotoshi Ebinuma; Hiroyoshi Kunimoto; Shinichir 📂 Article 📅 2008 🏛 Springer Japan 🌐 English ⚖ 305 KB

Delayed hepatitis B virus reactivation a

Delayed hepatitis B virus reactivation after cessation of preemptive lamivudine in lymphoma patients treated with rituximab plus CHOP

✍ Ming-Shen Dai; Tsu-Yi Chao; Woei-Yau Kao; Rong-Yaun Shyu; Tan-Mei Liu 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 187 KB

Analysis of C-reactive protein levels an

Analysis of C-reactive protein levels and febrile tendency after joint surgery in rheumatoid arthritis patients treated with a perioperative 4-week interruption of tocilizumab

✍ Ryo Hiroshima; Kosei Kawakami; Takuji Iwamoto; Asami Tokita; Koichiro Yano; Yu S 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 187 KB

Improvement of renal function and disapp

Improvement of renal function and disappearance of hepatitis B virus DNA in a patient with rheumatoid arthritis and renal amyloidosis following treatment with infliximab

✍ Maria Grazia Anelli; Diletta Domenica Torres; Carlo Manno; Crescenzio Scioscia; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 38 KB 👁 2 views

Reactive systemic AA amyloidosis is a severe complication of rheumatoid arthritis (RA), occurring in 2-5% of RA patients (1). Infliximab, a monoclonal antibody against tumor necrosis factor ␣ (TNF␣), is successfully used in the treatment of RA (2). TNF␣ plays a key role in inducing the synthesis of

Use of tumor necrosis factor-α (TNF-α) a

Use of tumor necrosis factor-α (TNF-α) antagonists infliximab, etanercept, and adalimumab in patients with concurrent rheumatoid arthritis and hepatitis B or hepatitis C: a retrospective record review of 11 patients

✍ Sophia Li; Primal P. Kaur; Virginia Chan; Steven Berney 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 102 KB